R. Delva
- Oncology top 2%
- Cancer Treatment and Pharmacology 32
- Colorectal Cancer Treatments and Studies 10
-
- Prostate Cancer Treatment and Research 28
- Renal cell carcinoma treatment 17
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 12
- Cancer Genomics and Diagnostics 9
- Reproductive Medicine top 5%
- Hematology top 5%
-
- Testicular diseases and treatments 13
-
- Neuroblastoma Research and Treatments 9
- Co-authors
- Érick GamelinM. Boisdron‐CelleAlain MorelChristine ChevreauNorbert IfrahVéronique Guerin‐MeyerGwénaëlle GravisAlain Lortholary
- Journals
- Journal of Clinical Oncology (39 papers)Annals of Oncology (14 papers)European Journal of Cancer (6 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
R. Delva
96 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 1.3k
- Cancer Research 538
- Reproductive Medicine 160
- Hematology 196
Countries citing papers authored by R. Delva
This map shows the geographic impact of R. Delva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Delva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Delva more than expected).
Fields of papers citing papers by R. Delva
This network shows the impact of papers produced by R. Delva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Delva. The network helps show where R. Delva may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. Delva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 8 | |
| 5 | 2017 | 14 | |
| 6 | 2017 | 1 | |
| 7 | 2017 | 3 | |
| 8 | 2015 | 14 | |
| 9 | 2014 | 3 | |
| 10 | 2013 | 26 | |
| 11 | 2012 | 8 | |
| 12 | 2008 | 59 | |
| 13 | 2008 | 71 | |
| 14 | 2007 | 135 | |
| 15 | 2006 | 31 | |
| 16 | 2006 | 12 | |
| 17 | 2005 | 39 | |
| 18 | 2002 | 18 | |
| 19 | 2002 | 12 | |
| 20 | 1993 | 8 |
About R. Delva
R. Delva is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 99 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (32 papers), Prostate Cancer Treatment and Research (28 papers), Renal cell carcinoma treatment (17 papers), Testicular diseases and treatments (13 papers), Cancer, Lipids, and Metabolism (12 papers), Colorectal Cancer Treatments and Studies (10 papers), Cancer Genomics and Diagnostics (9 papers) and Neuroblastoma Research and Treatments (9 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Cancer Research (538 citations). R. Delva has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Érick Gamelin, M. Boisdron‐Celle, Alain Morel, Christine Chevreau, Norbert Ifrah, Véronique Guerin‐Meyer, Gwénaëlle Gravis, Alain Lortholary, F Larra and Sylvie Négrier. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.